Please use this identifier to cite or link to this item: https://dora.health.qld.gov.au/qldresearchjspui/handle/1/2007
Title: Auckland regional telemedicine retinopathy of prematurity screening network: A 10-year review
Authors: Dai, S. 
Han, J. V.
Misra, S. L.
Simkin, S. K.
McGhee, C. N. J.
Issue Date: 2019
Source: 47, (9), 2019, p. 1122-1130
Pages: 1122-1130
Journal: Clinical and Experimental Ophthalmology
Abstract: Importance: Retinopathy of prematurity (ROP) is a potentially blinding condition affecting the retinae of premature infants. Effective screening is necessary for timely treatment. Background: The Auckland Regional Telemedicine ROP (ART-ROP) network, utilizes wide-field digital imaging for ROP screening. This study reviews the ART-ROP network. Design: Retrospective analysis of the ART-ROP database. Participants: Files of infants in ART-ROP from 2006 to 2015. Methods: Data on infant demographics, ROP stage, treatment and outcome was collected. Main Outcome Measures: The efficacy of ART-ROP in the management of ROP. Results: A review of 1181 infants across three neonatal intensive care units, was completed. Infants had a mean of four screening sessions with no infants who met ROP screening criteria being missed. Type 1 ROP was present in 83 infants, who had significantly lower average birth weight 786 ± 191 g compared to 1077 ± 285 g (P <.001), and gestational age 25.3 ± 1.7 weeks compared to 27.8 ± 2.2 weeks (P <.001) than the screened cohort. The number of infants requiring screening increased (R2 =.7993), yet treatment rates decreased (R2 =.9205) across the time period. Out-patient clinic follow-up was attended by 75.10% of infants screened and there was no missed ROP in those infants seen. Conclusions and Relevance: ART-ROP solely uses wide-field digital imaging for ROP diagnosis, and management, including discharge, of infants. This detailed review of ART-ROP indicates an increase in screening demand, but a decrease in the rate of type 1 ROP. The ART-ROP telemedicine model demonstrates real potential to address workforce shortage in ROP screening.L20024696502019-08-22
2020-01-03
DOI: 10.1111/ceo.13593
Resources: https://www.embase.com/search/results?subaction=viewrecord&id=L2002469650&from=exporthttp://dx.doi.org/10.1111/ceo.13593 |
Keywords: drug efficacy;European;female;gestational age;high risk infant;human;infant;low birth weight;low level laser therapy;major clinical study;male;Asian;mass screening;neonatal intensive care unit;Pacific Islander;retrolental fibroplasia;retrospective study;telemedicine;bevacizumabarticle;Maori (people);clinical effectiveness;controlled study;disease severity
Type: Article
Appears in Sites:Children's Health Queensland Publications

Show full item record

Page view(s)

94
checked on Mar 25, 2025

Google ScholarTM

Check

Altmetric


Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.